Chemdex: The On-Line Market for Bioscience

From inventory to the laboratory, the requisition of chemicals for research has just entered the computer age. David Perry's Chemdex Corp., an on-line marketplace for chemicals, may revolutionize the way researchers obtain specialty biochemicals in the research industry. Until recently, the process of ordering chemicals for research has had all the convenience and much of the flavor of a Persian bazaar. With hundreds of manufacturers and distributors vying with one another for a share of this

Written byBrent Johnson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

From inventory to the laboratory, the requisition of chemicals for research has just entered the computer age. David Perry's Chemdex Corp., an on-line marketplace for chemicals, may revolutionize the way researchers obtain specialty biochemicals in the research industry.

Until recently, the process of ordering chemicals for research has had all the convenience and much of the flavor of a Persian bazaar. With hundreds of manufacturers and distributors vying with one another for a share of this billion dollar market, the problem had been finding a consistent vendor that produces quality products.

Now that Chemdex has entered the marketplace, many of the headaches associated with finding the proper chemicals for laboratory experiments could be eliminated. According to Chemdex president and CEO David Perry, Chemdex offers over 120,000 products from 80 different companies. This number continues to grow by three to four additional suppliers per week and 20,000 products per month, making ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies